Q61337 (BAD_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 97.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Bcl2 antagonist of cell death Short name=BAD Alternative name(s): Bcl-2-binding component 6 Bcl-xL/Bcl-2-associated death promoter | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus |
Protein attributes
| Sequence length | 204 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Promotes cell death. Successfully competes for the binding to Bcl-X(L), Bcl-2 and Bcl-W, thereby affecting the level of heterodimerization of these proteins with BAX. Can reverse the death repressor activity of Bcl-X(L), but not that of Bcl-2. Appears to act as a link between growth factor receptor signaling and the apoptotic pathways. |
| Subunit structure | Forms heterodimers with the anti-apoptotic proteins, Bcl-X(L), Bcl-2 and Bcl-W. Also binds protein S100A10 By similarity. The Ser-112/Ser-136 phosphorylated form binds 14-3-3 proteins. Interacts with AKT1 and PIM3 By similarity. |
| Subcellular location | Mitochondrion outer membrane. Cytoplasm. Note: Upon phosphorylation, locates to the cytoplasm. |
| Domain | Intact BH3 motif is required by BIK, BID, BAK, BAD and BAX for their pro-apoptotic activity and for their interaction with anti-apoptotic members of the Bcl-2 family. |
| Post-translational modification | Phosphorylated on one or more of Ser-112, Ser-136, Ser-155 and Ser-170 in response to survival stimuli, which blocks its pro-apoptotic activity. Phosphorylation on Ser-136 or Ser-112 promotes heterodimerization with 14-3-3 proteins. This interaction then facilitates the phosphorylation at Ser-155, a site within the BH3 motif, leading to the release of Bcl-X(L) and the promotion of cell survival. Ser-136 is the major site of AKT/PKB phosphorylation, Ser-155 the major site of protein kinase A (CAPK) phosphorylation. Ref.3 Ref.4 Ref.6 Ref.7 Ref.8 Ref.9 Ref.10 Ref.11 Ref.12 Ref.13 |
| Sequence similarities | Belongs to the Bcl-2 family. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| BCL2 | P10415 | 5 | EBI-400328,EBI-77694 | From a different organism. |
| BCL2L1 | Q07817-1 | 2 | EBI-400328,EBI-287195 | From a different organism. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||
Molecule processing | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 204 | 204 | Bcl2 antagonist of cell death | PRO_0000143104 | ||||||||
Regions | ||||||||||||
| Motif | 147 – 161 | 15 | BH3 | |||||||||
Amino acid modifications | ||||||||||||
| Modified residue | 67 | 1 | Phosphoserine By similarity | |||||||||
| Modified residue | 112 | 1 | Phosphoserine; by PKA, PKB, PIM2, PIM3, PAK1, PAK2, PAK4, PAK7/PAK5, RPS6KA1 AND RAF1 Ref.3 Ref.4 Ref.6 Ref.7 Ref.11 Ref.12 Ref.13 | |||||||||
| Modified residue | 128 | 1 | Phosphoserine By similarity | |||||||||
| Modified residue | 136 | 1 | Phosphoserine; by PKA, PKB, PAK1, RPS6KA1, RPS6KB1 and PKC/PRKCQ Ref.3 Ref.4 Ref.6 Ref.8 Ref.9 | |||||||||
| Modified residue | 155 | 1 | Phosphoserine; by PKA and PKB | |||||||||
| Modified residue | 170 | 1 | Phosphoserine Ref.10 | |||||||||
Experimental info | ||||||||||||
| Mutagenesis | 112 | 1 | S → A: Enhances pro-apoptotic activity; no phosphorylation. Ref.3 Ref.5 Ref.10 | |||||||||
| Mutagenesis | 136 | 1 | S → A: No phosphorylation. Ref.3 Ref.5 | |||||||||
| Mutagenesis | 155 | 1 | S → A: Enhances pro-apoptotic activity; no phosphorylation; interacts with Bcl-X(L). Ref.5 Ref.10 | |||||||||
| Mutagenesis | 155 | 1 | S → D: No pro-apoptotic activity, no interaction with Bcl-X(L). Ref.5 Ref.10 | |||||||||
| Mutagenesis | 170 | 1 | S → A: Enhances pro-apoptotic activity. Ref.5 Ref.10 | |||||||||
| Mutagenesis | 170 | 1 | S → D: No pro-apoptotic activity; even when associated with A-112. Ref.5 Ref.10 | |||||||||
Secondary structure | ||||||||||||
Helix Strand Turn | ||||||||||||
| Helix | 139 – 141 | 3 | ||||||||||
| Helix | 142 – 160 | 19 | ||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death." Yang E., Zha J., Jockel J., Boise L.H., Thompson C.B., Korsmeyer S.J. Cell 80:285-291(1995) [PubMed: 7834748] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Brain and Thymus. |
| [2] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Strain: NMRI. Tissue: Mammary gland. |
| [3] | "Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt." Del Peso L., Gonzalez-Garcia M., Page C., Herrera R., Nunez G. Science 278:687-689(1997) [PubMed: 9381178] [Abstract] Cited for: PHOSPHORYLATION AT SER-112 AND SER-136, MUTAGENESIS OF SER-112 AND SER-136. |
| [4] | "Rsk1 mediates a MEK-MAP kinase cell survival signal." Shimamura A., Ballif B.A., Richards S.A., Blenis J. Curr. Biol. 10:127-135(2000) [PubMed: 10679322] [Abstract] Cited for: PHOSPHORYLATION AT SER-112 AND SER-136. |
| [5] | "14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation." Datta S.R., Katsov A., Hu L., Petros A., Fesik S.W., Yaffe M.B., Greenberg M.E. Mol. Cell 6:41-51(2000) [PubMed: 10949026] [Abstract] Cited for: MUTAGENESIS OF SERINE RESIDUES. |
| [6] | "p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis." Schurmann A., Mooney A.F., Sanders L.C., Sells M.A., Wang H.G., Reed J.C., Bokoch G.M. Mol. Cell. Biol. 20:453-461(2000) [PubMed: 10611223] [Abstract] Cited for: PHOSPHORYLATION AT SER-112 AND SER-136. |
| [7] | "p21-activated protein kinase gamma-PAK suppresses programmed cell death of BALB3T3 fibroblasts." Jakobi R., Moertl E., Koeppel M.A. J. Biol. Chem. 276:16624-16634(2001) [PubMed: 11278362] [Abstract] Cited for: PHOSPHORYLATION AT SER-112. |
| [8] | "Protein kinase C-theta mediates a selective T cell survival signal via phosphorylation of BAD." Villalba M., Bushway P., Altman A. J. Immunol. 166:5955-5963(2001) [PubMed: 11342610] [Abstract] Cited for: PHOSPHORYLATION AT SER-136. |
| [9] | "p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD." Harada H., Andersen J.S., Mann M., Terada N., Korsmeyer S.J. Proc. Natl. Acad. Sci. U.S.A. 98:9666-9670(2001) [PubMed: 11493700] [Abstract] Cited for: PHOSPHORYLATION AT SER-136. |
| [10] | "Identification of a novel phosphorylation site, Ser-170, as a regulator of bad pro-apoptotic activity." Dramsi S., Scheid M.P., Maiti A., Hojabrpour P., Chen X., Schubert K., Goodlett D.R., Aebersold R., Duronio V. J. Biol. Chem. 277:6399-6405(2002) [PubMed: 11717309] [Abstract] Cited for: PHOSPHORYLATION AT SER-170, MUTAGENESIS OF SER-112; SER-155 AND SER-170, MASS SPECTROMETRY. |
| [11] | "The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death." Yan B., Zemskova M., Holder S., Chin V., Kraft A., Koskinen P.J., Lilly M. J. Biol. Chem. 278:45358-45367(2003) [PubMed: 12954615] [Abstract] Cited for: PHOSPHORYLATION AT SER-112 BY PIM2. |
| [12] | "p21-activated Kinase 1 (Pak1)-dependent phosphorylation of Raf-1 regulates its mitochondrial localization, phosphorylation of BAD, and Bcl-2 association." Jin S., Zhuo Y., Guo W., Field J. J. Biol. Chem. 280:24698-24705(2005) [PubMed: 15849194] [Abstract] Cited for: PHOSPHORYLATION AT SER-112 BY RAF1. |
| [13] | "Large-scale phosphorylation analysis of mouse liver." Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007) [PubMed: 17242355] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-112, MASS SPECTROMETRY. Tissue: Liver. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | L37296 mRNA. Translation: AAA64465.1. BC006762 mRNA. Translation: AAH06762.1. | ||||||||||||
| IPI | IPI00119986. | ||||||||||||
| PIR | A55671. | ||||||||||||
| RefSeq | NP_031548.1. NM_007522.2. | ||||||||||||
| UniGene | Mm.4387. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q61337. | ||||||||||||
| SMR | Q61337. Positions 137-163. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-273N. | ||||||||||||
| IntAct | Q61337. 6 interactions. | ||||||||||||
| STRING | Q61337. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q61337. | ||||||||||||
Proteomic databases | |||||||||||||
| PRIDE | Q61337. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENSMUST00000025910; ENSMUSP00000025910; ENSMUSG00000024959. | ||||||||||||
| GeneID | 12015. | ||||||||||||
| KEGG | mmu:12015. | ||||||||||||
| UCSC | uc008gjn.1. mouse. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 572. | ||||||||||||
| MGI | MGI:1096330. Bad. | ||||||||||||
Phylogenomic databases | |||||||||||||
| GeneTree | ENSGT00390000010740. | ||||||||||||
| HOGENOM | HBG125823. | ||||||||||||
| HOVERGEN | HBG001653. | ||||||||||||
| InParanoid | Q61337. | ||||||||||||
| OMA | SFKGLPR. | ||||||||||||
| OrthoDB | EOG42RD8W. | ||||||||||||
| PhylomeDB | Q61337. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q61337. | ||||||||||||
| Bgee | Q61337. | ||||||||||||
| CleanEx | MM_BAD. | ||||||||||||
| Genevestigator | Q61337. | ||||||||||||
| GermOnline | ENSMUSG00000024959. Mus musculus. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR018868. Bcl-2_BAD. [Graphical view] | ||||||||||||
| KO | K02158. | ||||||||||||
| Pfam | PF10514. Bcl-2_BAD. 1 hit. [Graphical view] | ||||||||||||
| PROSITE | PS01259. BH3. False negative. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| NextBio | 280229. | ||||||||||||
| PMAP-CutDB | Q61337. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | BAD_MOUSE | ||||||||
| Accession | Primary (citable) accession number: Q61337 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with